Toxicity testing or safety assessment is a major part of the preclinical safety evaluation related to drug development. Aginko offers safety programs in accordance with guidelines and regulations, ranging from acute to chronic toxicity and cardiogenecity studies.
We also offer a broad range of animal models as well as numerous route of administration.

AGINKO proposes a series of tests for general toxicology assessment. We understand how critical development support is from concept through essential safety and efficacy studies. Toxicologists working with Aginko have experience with a variety of compounds and therapeutic areas. Our staff provides the safety services to support analytical and bioanalytical studies for pharmaceutical product development. We are all dedicated to quality and excellence. Our goal is to provide aqually reliable data for an accurate and balanced assessment.

Dermal (open, semi-occluded and occluded dressing, patches and other devices, with or without rinsing, with or without collar)

Ocular (including intra-vitreous)

Intra-nasal

Inhalation (in non-rodents)

Intra-vaginal

We have experience in a number of very specific routes of administrations in different species and each study is adapted to the specificity of the product.

At Aginko we are committed to learn and understand your objectives for your product development in order to meet regulatories requirements. For personalized and adapted toxicology study designs do not hesitate to contact us.

We also conduct studies with very specific adapted designs (adapted to the tested product and specific national regulatory requirements if needed).